¼¼°èÀÇ ÀÇ·á¿ë Æú¸®Ä«º¸³×ÀÌÆ® ½ÃÀå º¸°í¼­(2025³â)
Medical Polycarbonate Global Market Report 2025
»óǰÄÚµå : 1705351
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,426,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,288,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 12,150,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

ÀÇ·á¿ë Æú¸®Ä«º¸³×ÀÌÆ® ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â µ¿¾È °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2029³â±îÁö ¿¬Æò±Õ 6.9%ÀÇ CAGR·Î 19¾ï 6,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾ÈÀÇ ¼ºÀåÀº »õ·Î¿î ÀÇ·á ¿ëµµ¿¡ ´ëÇÑ R&D ÅõÀÚ Áõ°¡, »ýüÀûÇÕ¼º Àç·á¿¡ ´ëÇÑ ¼±È£µµ Áõ°¡, ½ÉÇ÷°üÁúȯÀÇ Áõ°¡, ¼ö¼ú °Ç¼ö Áõ°¡, ½ÅÈï °æÁ¦±¹ÀÇ ÀÇ·á ÀÎÇÁ¶ó È®´ë¿¡ ±âÀÎÇÕ´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ±â¼ú ¹ßÀü, Àü·«Àû Á¦ÈÞ, °øÀå È®Àå, ¸ÂÃãÇü ÀÇ·á±â±â¿¡ ÀûÃþ ¼ºÇü äÅÃ, Â÷¼¼´ë ¿þ¾î·¯ºí ÀÇ·á±â¼ú¿¡ Æú¸®Ä«º¸³×ÀÌÆ®ÀÇ ÅëÇÕ µîÀÌ ÀÖ½À´Ï´Ù.

¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡´Â ÇâÈÄ ¸î ³â µ¿¾È ÀÇ·á¿ë Æú¸®Ä«º¸³×ÀÌÆ® ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¸¸¼ºÁúȯÀº Áö¼ÓÀûÀÎ Ä¡·á°¡ ÇÊ¿äÇϰí ÀÏ»ó»ýȰ°ú »îÀÇ ÁúÀ» Á¦ÇÑÇÒ ¼ö ÀÖ´Â Àå±âÀûÀÎ »óŸ¦ Ư¡À¸·Î Çϸç, »ýȰ½À°üÀÇ º¯È­, À¯ÀüÀû ¼ÒÀÎ, ȯ°æ¿À¿°¹°Áú ¹× µ¶¼Ò ³ëÃâ µî ´Ù¾çÇÑ ¿äÀο¡ ÀÇÇØ Áõ°¡ Ãß¼¼¿¡ ÀÖ½À´Ï´Ù. ÀÇ·á¿ë Æú¸®Ä«º¸³×ÀÌÆ®´Â ¸¸¼ºÁúȯÀÇ Ä¡·á, Áø´Ü, ¸ð´ÏÅ͸µ¿¡ ÇʼöÀûÀÎ ÀåÄ¡ ¹× ±â±â¿¡ Àû¿ëµÇ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 1¿ù ¹Ì±¹ ±¹¸³»ý¹°°øÇÐÁ¤º¸¼¾ÅÍ(NCBI)°¡ ¹ßÇ¥ÇÑ º¸°í¼­¿¡ µû¸£¸é 2050³â±îÁö 50¼¼ À̻󿡼­ 1°³ ÀÌ»óÀÇ ¸¸¼ºÁúȯÀ» ¾Î°í ÀÖ´Â »ç¶÷ÀÇ ¼ö°¡ 99.5% Áõ°¡ÇÏ¿© 2020³â 7,152¸¸ 2,000¸í¿¡¼­ 1¾ï 4,266¸¸ ¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. µû¶ó¼­ ¸¸¼ºÁúȯÀÇ È®»êÀº ÀÇ·á¿ë Æú¸®Ä«º¸³×ÀÌÆ® ½ÃÀåÀÇ Áß¿äÇÑ ÃËÁø¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù.

ÀÇ·á¿ë Æú¸®Ä«º¸³×ÀÌÆ® ½ÃÀåÀÇ ÁÖ¿ä ¾÷üµéÀº °æÀï·ÂÀ» À¯ÁöÇϱâ À§ÇØ ÇコÄÉ¾î ¹× »ý¸í°úÇÐ ºÐ¾ß¿¡ ¸ÂÃá Ãʳ»±¸¼º ¼ÒÀç ¼Ö·ç¼Ç°ú °°Àº Çõ½ÅÀûÀÎ Á¦Ç° °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. Ãʳ»±¸¼º ¼ÒÀç ¼Ö·ç¼ÇÀº Å« ¿­È­³ª °íÀå ¾øÀÌ °¡È¤ÇÑ Á¶°Ç°ú ½ºÆ®·¹½º¸¦ °ßµô ¼ö ÀÖµµ·Ï ¼³°èµÈ ¼ÒÀ縦 ¸»ÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, ÄÚº£½ºÆ®·Î AG´Â 2023³â 2¿ù ¶Ù¾î³­ °­µµ, ³»È­Çмº, »ýüÀûÇÕ¼ºÀ¸·Î À¯¸íÇÑ Ãʳ»±¸¼º ¼ÒÀçÀÎ Makrolon 3638 Æú¸®Ä«º¸³×ÀÌÆ®¸¦ Ãâ½ÃÇß½À´Ï´Ù. Àå½Ã°£ »ç¿ë ¹× ¸ê±ÕÀÌ ÇÊ¿äÇÑ ÀÇ·á±â±â ¹× ÀåÄ¡¿ëÀ¸·Î ¼³°èµÈ ÀÌ Çõ½ÅÀûÀÎ ¼ÒÀç´Â ¿­ ¾ÈÁ¤¼ºÀÌ ¶Ù¾î³ª ¿­¾ÇÇÑ Á¶°Ç¿¡¼­µµ ¾ÈÁ¤ÀûÀÎ ¼º´ÉÀ» ¹ßÈÖÇϸç, ÀæÀº ±³Ã¼ Çʿ伺À» ÁÙ¿© ÀÇ·á¿ë ¾ÖÇø®ÄÉÀ̼ÇÀÇ ºñ¿ë È¿À²¼º°ú ½Å·Ú¼ºÀ» ³ôÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ½ÅÁ¾ Äڷγª¹ÙÀÌ·¯½º °¨¿°Áõ, ±×¸®°í °æ±âȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°¡¤±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷°ú Çõ½ÅÀû ±â¾÷

Á¦32Àå ¼¼°èÀÇ ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´

Á¦34Àå ÃÖ±ÙÀÇ ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Medical polycarbonate stands as a specialized form of polycarbonate material tailored and produced explicitly for medical purposes. Its application extends to the manufacturing of diverse medical devices and equipment, owing to its biocompatibility, capacity for sterilization, and resilience to repeated cleaning and sterilization cycles.

The primary grades within the medical polycarbonate market encompass lipid-resistant grade, high-temperature grade, and other classifications. Lipid-resistant grade polycarbonate, a subset of medical-grade polycarbonate, is meticulously engineered to endure exposure to lipid emulsions, frequently utilized in intravenous (IV) therapy. Various processing technologies, including extrusion, injection molding, blow molding, and others, are deployed across a range of applications such as fluid delivery and IV connection components, renal dialysis products, cardiovascular devices, surgical instruments, among others.

The medical polycarbonate market research report is one of a series of new reports from The Business Research Company that provides medical polycarbonate market statistics, including medical polycarbonate industry global market size, regional shares, competitors with a medical polycarbonate market share, detailed medical polycarbonate market segments, market trends, and opportunities, and any further data you may need to thrive in the medical polycarbonate industry. This medical polycarbonate research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The medical polycarbonate market size has grown strongly in recent years. It will grow from $1.4 billion in 2024 to $1.5 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to increased demand for personal protective equipment, increased prevalence of chronic diseases, increasing demand for durable and lightweight materials, rise in the number of diseases, and stringent regulatory standards.

The medical polycarbonate market size is expected to see strong growth in the next few years. It will grow to $1.96 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to rising investments in research and development for novel medical applications, growing preference for biocompatible materials, increased number of cardiovascular diseases, increased number of surgeries, and expanding healthcare infrastructure in emerging economies. Major trends in the forecast period include technological advancements, strategic collaborations, factory expansion, adoption of additive manufacturing for customized medical devices, and integration of polycarbonate in next-generation wearable health technologies.

The increasing prevalence of chronic diseases is poised to drive the growth of the medical polycarbonate market in the coming years. Chronic diseases, characterized by long-lasting conditions requiring ongoing medical attention and potentially limiting daily activities or quality of life, are on the rise due to various factors such as lifestyle changes, genetic predisposition, and exposure to environmental pollutants and toxins. Medical polycarbonate finds application in devices and instruments crucial for the treatment, diagnosis, and monitoring of chronic illnesses. For instance, a report from the National Center for Biotechnology Information (NCBI) in January 2023 projected a 99.5% increase in the number of individuals aged 50 and above suffering from one or more chronic diseases by 2050, reaching 142.66 million from 71.522 million in 2020. Hence, the growing prevalence of chronic diseases is a significant driver for the medical polycarbonate market.

Key players in the medical polycarbonate market are focusing on the development of innovative products, such as ultra-durable material solutions tailored for the healthcare and life sciences sectors, to maintain a competitive edge. Ultra-durable material solutions refer to materials engineered to withstand harsh conditions and stresses without significant degradation or failure. For example, in February 2023, Covestro AG introduced Makrolon 3638 polycarbonate, an ultra-durable material renowned for its exceptional strength, chemical resistance, and biocompatibility. Designed for medical devices and equipment requiring prolonged use and sterilization, this innovative material offers high thermal stability for consistent performance in extreme conditions, reducing the need for frequent replacements and enhancing cost-efficiency and reliability in medical applications.

In November 2022, Celanese Corporation completed the acquisition of DuPont de Nemours Inc.'s mobility and materials business for $11 billion. This strategic move aims to bolster Celanese's capabilities in the high-performance materials sector, expanding its portfolio of engineering thermoplastics, elastomers, and specialty polymers. DuPont de Nemours Inc. is a leading manufacturer of chemicals and specialty materials, including medical polycarbonate.

Major companies operating in the medical polycarbonate market are Bayer AG, LG Chem Ltd., Saudi Basic Industries Corporation, Asahi Kasei Corporation, Covestro AG, Lotte Chemical Corporation, Evonik Industries AG, Royal DSM N.V., Celanese Corporation, Teijin Limited, Trinseo S.A., Kolon Industries Inc., Avient Corporation, Daicel Corporation, Tekni-Plex Inc., Plaskolite LLC, RTP Company, Mitsubishi Engineering-Plastics Corporation, Chi Mei Corporation, Polyplastics Co. Ltd.

North America was the largest region in the medical polycarbonate market in 2024. The regions covered in the medical polycarbonate market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the medical polycarbonate market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The medical polycarbonate market consists of sales of medical imaging equipment, surgical instruments, drug delivery devices, and ophthalmological devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Medical Polycarbonate Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on medical polycarbonate market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for medical polycarbonate ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The medical polycarbonate market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Medical Polycarbonate Market Characteristics

3. Medical Polycarbonate Market Trends And Strategies

4. Medical Polycarbonate Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Medical Polycarbonate Growth Analysis And Strategic Analysis Framework

6. Medical Polycarbonate Market Segmentation

7. Medical Polycarbonate Market Regional And Country Analysis

8. Asia-Pacific Medical Polycarbonate Market

9. China Medical Polycarbonate Market

10. India Medical Polycarbonate Market

11. Japan Medical Polycarbonate Market

12. Australia Medical Polycarbonate Market

13. Indonesia Medical Polycarbonate Market

14. South Korea Medical Polycarbonate Market

15. Western Europe Medical Polycarbonate Market

16. UK Medical Polycarbonate Market

17. Germany Medical Polycarbonate Market

18. France Medical Polycarbonate Market

19. Italy Medical Polycarbonate Market

20. Spain Medical Polycarbonate Market

21. Eastern Europe Medical Polycarbonate Market

22. Russia Medical Polycarbonate Market

23. North America Medical Polycarbonate Market

24. USA Medical Polycarbonate Market

25. Canada Medical Polycarbonate Market

26. South America Medical Polycarbonate Market

27. Brazil Medical Polycarbonate Market

28. Middle East Medical Polycarbonate Market

29. Africa Medical Polycarbonate Market

30. Medical Polycarbonate Market Competitive Landscape And Company Profiles

31. Medical Polycarbonate Market Other Major And Innovative Companies

32. Global Medical Polycarbonate Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Medical Polycarbonate Market

34. Recent Developments In The Medical Polycarbonate Market

35. Medical Polycarbonate Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â